Medicine & Life Sciences

1. Lymphoma 100%
2. Lymphoma, Large B-Cell, Diffuse 82%
3. Non-Hodgkin's Lymphoma 80%
4. Survival 68%
5. B-Cell Lymphoma 54%
6. Hodgkin Disease 54%
7. Progression-Free Survival 52%
8. Stem Cell Transplantation 52%
9. Peripheral Blood Stem Cell Transplantation 40%
10. Chimeric Antigen Receptors 40%
11. Lymphocyte Count 39%
12. Rituximab 38%
13. Hematopoietic Stem Cell Transplantation 36%
14. axicabtagene ciloleucel 36%
15. Follicular Lymphoma 33%
16. Everolimus 32%
17. Monocytes 29%
18. Lymphocytes 28%
19. Autografts 28%
20. Mantle-Cell Lymphoma 26%
21. Drug Therapy 25%
22. Transplants 23%
23. Stem Cells 22%
24. Therapeutics 21%
25. T-Lymphocytes 20%
26. Recurrence 20%
27. Cell- and Tissue-Based Therapy 20%
28. Lenalidomide 19%
29. B-Lymphocytes 19%
30. ibritumomab tiuxetan 18%
31. zanubrutinib 17%
32. T-Cell Lymphoma 17%
33. Cyclophosphamide 17%
34. Confidence Intervals 17%
35. Central Nervous System 15%
36. Multiple Myeloma 14%
37. Radioimmunotherapy 14%
38. Vincristine 14%
39. Prednisone 13%
40. fludarabine 13%
41. Doxorubicin 12%
42. Standard of Care 12%
43. Methotrexate 12%
44. B-Cell Chronic Lymphocytic Leukemia 12%
45. Melphalan 11%
46. Glycoproteins 11%
47. Immunoglobulin Light-chain Amyloidosis 11%
48. Waldenstrom Macroglobulinemia 11%
49. Dexamethasone 11%
50. Adoptive Immunotherapy 10%